{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-405.17",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 405.17 - Pharmaceutical services",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 405.17 - Pharmaceutical services\n\nState Regulations\n\nThe hospital shall provide pharmaceutical services that\nare available at all times on the premises to meet the needs of the patients. The hospital shall have a pharmacy that is registered and operated in\naccordance with article 137 of the New York State Education Law and is directed\nby a registered pharmacist trained in the specialized functions of hospital\npharmacy. (a) Organization and\ndirection. The pharmacy shall be responsible, in conjunction with\nthe medical staff, for ensuring the health and safety of patients through the\norganization, management and operation of the service in accordance with\ngenerally accepted professional principles and the proper selection, storage, preparation, distribution, use, control, disposal and accountability of drugs\nand pharmaceuticals. (1)\n\nThe director\nshall be employed on a full-time or part-time basis based on the needs of the\nhospital. (2)\n\nThe director, in\nconjunction with designated members of the medical staff, shall ensure that: (i) for patients of all ages weight shall be\nmeasured in metric units. Up-to-date drug information reference systems\nrelating to drug interactions, drug therapies, side effects, toxicology, dosage, indications for use, and routes of administration are available to the\nprofessional staff. Pediatric dosing resources shall include age and size\nappropriate fluid and medication administration and dosing. Pediatric dosing\nmust be weight based, should include the calculated dose, the dosing\ndetermination, such as the dose per weight (\ne.g., milligrams\nper kilogram) or body surface area, to facilitate an independent double-check\nof the calculation, and should not exceed adult maximum dosage, or in\nemergencies, length based; (ii)\na\nformulary is established and reviewed at least annually and updated as\nnecessary to meet the needs of the patients for use in the hospital to assure\nquality pharmaceuticals at reasonable costs; (iii)\nstandards are established concerning\nthe use and control of investigational drugs and research in the use of\nrecognized drugs; (iv)\nclinical\ndata are evaluated concerning new drugs or preparations requested for use in\nthe hospital; and\n(v) the list of\nfloor stock medication is reviewed and recommendations are made concerning\ndrugs to be stocked on the nursing unit floors and by other services. (3)\n\nThe director shall be\nresponsible for developing and implementing written policies and procedures for\nthe intrahospital distribution of drugs. (4)\n\nEffective October 1, 1990, each hospital\nshall have implemented a unit-dose distribution system. (5)\n\nThe pharmaceutical service shall have an\nadequate number of registered pharmacists and other qualified personnel to\nensure the availability of quality services including emergency services, 24\nhours per day, seven days per week. (6)\n\nAll drug storage, preparation and\ndispensing shall be under the supervision of the director and shall be\nmonitored for adherence to hospital policies and procedures. Monitoring reports\nshall be documented and available for inspection. (7)\n\nThe director shall ensure that current\nand accurate records are kept of the transactions of the pharmacy, including\nbut not limited to: (i) a system of records\nand bookkeeping in accordance with the policies of the hospital for: (a) maintaining adequate control over the\nrequisitioning and dispensing of all drugs and pharmaceutical supplies; and\n(b) charging patients for drugs\nand pharmaceutical supplies; (ii)\na record of inventory and dispensing of\nall controlled substances maintained in accordance with article 33 of the\n\nPublic Health Law and Part 80 of this Title; and\n(iii)\nthe labeling of all inpatient and\noutpatient medications in accordance with article 137 of the State Education\n\nLaw and 8 NYCRR section 29.7. (8)\n\nThe director shall ensure that drug\nmonitoring services are provided appropriate to each inpatient's needs. This\nshall include, but not be limited to, the maintenance of a medication record or\ndrug profile for each inpatient which is based on available drug history and\ncurrent therapy. (9)\n\nThe director\nwill ensure that there is a quality assurance program to monitor personnel\nqualifications, training, performance, equipment and facilities. (i) The director shall require and document\nthe participation of pharmacy personnel in relevant education programs, including orientation of new employees as well as inservice and outside\ncontinuing education programs. (ii)\n\nThe quality assurance program shall include policies, procedures and monitoring\nand improvement activities to identify, measure, prevent, minimize and/or\nmitigate adverse drug events, adverse drug reactions and medication errors in\naccordance with generally accepted standards and practices in the field of\nmedication safety and quality improvement. (iii)\n\nThe director in conjunction with the\nmedical staff shall ensure the monitoring and evaluation of the quality and\nappropriateness of patient services provided by the pharmaceutical\nservice. (10)\n\nThe\ndirector shall participate in those aspects of the hospital's overall quality\nassurance program that relate to drug utilization and effectiveness. (b) Operation and service\ndelivery. All drugs and biologicals shall be controlled and\ndistributed in accordance with written policies and procedures to maximize\npatient safety and quality of care. (1)\n\nThe compounding, preparation, labeling or\ndispensing of drugs shall be performed by a licensed pharmacist or pharmacy\nintern in accordance with applicable State and Federal laws, rules and\nregulations. (2)\n\nAll packing and\nrepacking of medications shall be performed in the pharmacy by or under the\ndirect supervision of a pharmacist in accordance with article 137 of the State\n\nEducation Law. (i) Written policies and\nprocedures shall indicate how such packages shall be labeled to identify the\nlot number or reference code and manufacturer's or distributor's name for\nproper identification and safety. (ii)\n\nRepacking and inventory records shall be\nmaintained by the pharmacy. (iii)\n\nWritten policies and procedures shall specify those medications which will not\nbe obtained from manufacturers or distributors in single unit packages and\nthose which will not be repackaged as single units in the facility. (3)\n\nPolicies and procedures for\nthe unit-dose drug distribution system shall be developed and implemented and\nshall include, but not be limited to: (i) each\npatient shall have his or her own receptacle, such as a tray, bin, box\ncassette, drawer or compartment, appropriately labeled as to patient, and\ncontaining his or her own medications. Each single unit package of medication\nshall be labeled in accordance with requirements set forth in article 137 of\nthe State Education Law; (ii)\ndelivery and exchange of patient medications shall occur as scheduled and as\nspecified in the service's written policies and procedures. Not more than a\n72-hour supply of prescribed medications shall be delivered to or available in\nthe patient care area at any time; (iii)\nmethods for procuring drugs on a\nroutine basis, in emergencies and in the event of disaster shall be identified\nin the service's written policies and procedures; and\n(iv)\nwritten policies and procedures shall be\ndeveloped and implemented regarding emergency kits and emergency carts\nincluding provisions for ensuring that emergency kits are secure and accessible\nand are specific to service locations, but are not kept under lock and key; (a) locations and contents shall be\nidentified and approved by the pharmaceutical service and the medical\nstaff; (b) frequency of checking\ncontents and expiration dates shall be specified in written policies and\nprocedures. (4)\n\nOutdated, mislabeled, discontinued, expired or otherwise unusable drugs and biologicals shall not be available for\npatient use. (5)\nA procedure shall\nbe developed to provide for the availability of drugs and biologicals during\nperiods of time when a pharmacist may not be immediately available. (6)\n\nDrugs and biologicals not specifically\nprescribed as to time or number of doses shall automatically be stopped after a\ntime that is specified in the service's policies and procedures as determined\nby the medical staff. (7)\n\nPolicies\nand procedures shall be developed and implemented for documenting, reviewing\nand, as appropriate, reporting dispensing errors, adverse drug reactions and\ndrug defects. (c) Physical facilities. The hospital shall provide facilities for the storage, safeguarding, preparation, and dispensing of drugs. (1)\n\nFloor stock medications shall be issued\nto floor units in accordance with the facility's written policies and\nprocedures: (i) all floor stocks must be\nproperly controlled and shall be limited to those medications identified on an\napproved floor stock list; (ii)\nfloor stock will be checked at least monthly by or under the direct supervision\nof a pharmacist for outdated and unauthorized medications. (2)\n\nAll drugs and biologicals shall be stored\nin locked storage areas and all controlled substances shall be stored in\naccordance with the storage requirements set forth in article 33 of the Public\n\nHealth Law and Part 80 of this Title. (3)\n\nAll abuses and losses of controlled\nsubstances shall be reported to the director, and to the medical staff, as\nappropriate, in accordance with applicable Federal and State laws. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n405.17\n\nAmended\n\nNew\n\nYork State Register November 13, 2019/Volume XLI, Issue 46, eff. 11/13/2019\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 4426
}